Spineology earns FDA clearance for Rampart One system: 3 points

The FDA cleared Spineology’s Rampart One Anterior Lumbar Interbody Fusion System, according to Twin Cities Business.

Advertisement

Here are three points:

 

1. The device is designed to help treat patients with lumbar degenerative disc disease.

 

2. Surgeons screw the device into the spine’s lumbar end during ALIF procedures.

 

3. The Rampart One is Spineology’s first product in the anterior spine market.

 

More articles on devices:
FDA clears K2M’s Capri Small 3D Static Corpectomy System: 4 key notes
ChoiceSpine launches biologics line: 5 takeaways
InVivo Therapeutics enrolls 17th patient in INSPIRE study: 4 notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.